XW1 Transfusion - Anatomical Regions ICD-10-PCS
The XW1 code range contains 25 ICD-10-PCS codes for Transfusion procedures on the anatomical regions. 24 of the codes are billable and valid for inpatient claim submission in fiscal year 2026.
Root Operation Definition
Transfusion: Putting in blood or blood products.
Codes in the XW1 Range 25 codes · 24 billable
- XW1 New Technology, Anatomical Regions, TransfusionNon-billable header
- XW13325 Transfusion of Convalescent Plasma (Nonautologous) into Peripheral Vein, Percutaneous Approach, New Technology Group 5
- XW1337A Transfusion of Marnetegragene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 10 New
- XW133B8 Transfusion of Betibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
- XW133C8 Transfusion of Omidubicel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
- XW133D7 Transfusion of High-Dose Intravenous Immune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7
- XW133E7 Transfusion of Hyperimmune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7
- XW133F8 Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8
- XW133G8 Transfusion of OTL-200 into Peripheral Vein, Percutaneous Approach, New Technology Group 8
- XW133H9 Transfusion of Lovotibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 9
- XW133J8 Transfusion of Exagamglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
- XW14325 Transfusion of Convalescent Plasma (Nonautologous) into Central Vein, Percutaneous Approach, New Technology Group 5
- XW1437A Transfusion of Marnetegragene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 10 New
- XW143B8 Transfusion of Betibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8
- XW143C8 Transfusion of Omidubicel into Central Vein, Percutaneous Approach, New Technology Group 8
- XW143D7 Transfusion of High-Dose Intravenous Immune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7
- XW143E7 Transfusion of Hyperimmune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7
- XW143F8 Transfusion of OTL-103 into Central Vein, Percutaneous Approach, New Technology Group 8
- XW143G8 Transfusion of OTL-200 into Central Vein, Percutaneous Approach, New Technology Group 8
- XW143H9 Transfusion of Lovotibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 9
- XW143J8 Transfusion of Exagamglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8
- XW133SB Transfusion of Mozafancogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 11 New
- XW133YB Transfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Peripheral Vein, Percutaneous Approach, New Technology Group 11 New
- XW143SB Transfusion of Mozafancogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 11 New
- XW143YB Transfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Central Vein, Percutaneous Approach, New Technology Group 11 New
About the XW1 Code Range
The ICD-10-PCS root operation Transfusion (code XW1) under the New Technology section involves the administration of blood products or cellular therapies into a blood vessel. This operation specifically covers the transfer of therapeutic substances to support or replace blood components or immune functions.
This ICD-10-PCS Transfusion operation is performed via a Percutaneous Approach into either a Peripheral Vein or Central Vein. The detailed codes represent transfusions of advanced therapies such as Convalescent Plasma (Nonautologous), Marnetegragene Autotemcel, and various immune globulins, highlighting the procedure’s use in innovative treatments. For example, code XW13325 describes a transfusion of convalescent plasma into a peripheral vein, while XW1437A refers to transfusion of Marnetegragene Autotemcel into a central vein. These codes denote the precision in coding modern transfusion techniques within the anatomical regions category, facilitating accurate procedural documentation for novel therapies.
The ICD-10-PCS root operation Transfusion (code XW1) under the New Technology section involves the transfer of blood or blood products into a patient’s anatomical region. This procedure introduces these substances to manage or treat various medical conditions through a controlled infusion.
Specifically, ICD-10-PCS transfusion codes capture transfusions performed via a Percutaneous Approach into either a Peripheral Vein or a Central Vein. The codes identify the distinct types of biological products used, such as Convalescent Plasma (Nonautologous) (XW13325 for peripheral vein), immune globulins, and advanced genetically engineered cell therapies like Marnetegragene Autotemcel (XW1337A), Betibeglogene Autotemcel, and others. These codes also distinguish the specific New Technology Groups representing different biotechnology products. Properly applying these codes ensures precise documentation of innovative transfusion therapies in the evolving landscape of medical treatment.
Questions About This Page
How many billable codes are in the XW1 range?
Of the 25 codes in this range, 24 are billable and valid for inpatient claim submission from October 1, 2025 through September 30, 2026. Table header codes group them but cannot be reported on claims.
What does the XW1 range classify?
The range classifies Transfusion procedures, putting in blood or blood products, performed on the anatomical regions. Each code adds the body part, approach, device, and qualifier in characters four through seven, and links to its own reference page.
Related References
Source: CMS FY 2026 ICD-10-PCS order file and code tables, effective October 1, 2025 through September 30, 2026.
